Andere Sprachen Evotec SE

Aktien

566480

DE0005664809

EVT

Biotechnologie

Markt geschlossen - Xetra Andere Börsenplätze 17:35:29 10.12.2024			Nachbörslich 21:58:00
8,810 ^EUR	-0,45 %		8,825	+0,17 %

06:20	ÜBERBLICK/Anstehende Indexänderungen zum 23. Dezember	DJ
09.12.	ÜBERBLICK/Anstehende Indexänderungen zum 23. Dezember	DJ

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Evotec announces change in Management Board	02.12.
Evotec SE: Correction of a release from 27/11/2024 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	02.12.
Sector Update: Health Care Stocks Rise in Afternoon Trading	29.11.
Evotec : announces change in Management Board Form 6 K	29.11.
NVR: Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	29.11.
Evotec COO to Step Down by End-2024	29.11.
Evotec Chief Operating Officer to Step Down at End of December	29.11.
Evotec SE Announces Craig Johnstone to Step Down and Leave as Chief Operating Officer, Effective 31 December 2024	29.11.
Evotec announces change in Management Board	29.11.
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	27.11.
Evotec SE - Ad hoc, Comment on withdrawn non-binding offer	25.11.
Trump séduit Wall Street avec Bessent	25.11.
En Direct des Marchés : ça bouge sur Atos, Unicredit veut croquer Banco BPM	25.11.
Evotec Refutes Halozyme Therapeutics' Reason for Buyout Bid Withdrawal	25.11.
Sector Update: Health Care Stocks Rise Friday Afternoon	22.11.
Hamburg, Germany – Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO) Form 6 K	22.11.
Comment on withdrawn non-binding offer	22.11.
Halozyme Therapeutics Withdraws Proposal to Acquire Evotec	22.11.
Sector Update: Health Care	22.11.
Halozyme Therapeutics Withdraws Proposal to Acquire Evotec	22.11.
Halozyme Therapeutics Withdraws Proposal to Acquire Evotec, Bloomberg Reports	22.11.
Halozyme withdraws $2.1 billion buyout offer for Evotec	22.11.
Halozyme Therapeutics, Inc. cancelled the acquisition of Evotec SE.	22.11.
Recursion Pharmaceuticals, Inc. completed the acquisition of Exscientia plc.	20.11.
Sector Update: Health Care Stocks Retreat Friday Afternoon	15.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Evotec SE

Aktien

566480

DE0005664809

EVT

Biotechnologie

Andere Sprachen

Filter